title: [Position of the German Society of Gynecology and Obstetrics on the intended recall of approved CPA-containing drugs].
authors.affiliation: Universitäts-Frauenklinik, Heidelberg, Deutschland.
authors.forename: J
authors.initials: J
authors.lastname: Hammerstein
authors.forename: T
authors.initials: T
authors.lastname: Rabe
authors.forename: B
authors.initials: B
authors.lastname: Runnebaum
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D017373:Cyproterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005260:Female; D005858:Germany; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced*; D011358:Product Surveillance, Postmarketing; D012955:Societies, Medical
chemical_list: D017373:Cyproterone Acetate
vernacular_title: Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe zum beabsichtigten Widerruf der Zulassung CPA-haltiger Präparate.